Rhabdomyolysis and neuroleptic malignant syndrome associated with very low-dose antipsychotics in children and adolescent

Research output: Contribution to journalJournal articlepeer-review

Abstract

Along with the field of adult psychiatry, antipsychotic agents are increasingly used in the field of child and adolescent psychiatry. Although neuroleptic malignant syndrome (NMS) and rhabdomyolysis are rare complication associated with antipsychotic agent, clinicians should need to pay attention to all potential adverse drug reaction (ADR). Also, ADRs in child and adolescent could show different signs and symptoms compared with those in adult. In this case report, we present a case of NMS in a child which occurred shortly after the resolution of rhabdomyolysis which was induced by low-dose risperidone.

Original languageEnglish
Pages (from-to)450-452
Number of pages3
JournalClinical Psychopharmacology and Neuroscience
Volume17
Issue number3
DOIs
StatePublished - 2019

Keywords

  • Neuroleptic malignant syndrome
  • Rhabdomyolysis
  • Risperidone

Quacquarelli Symonds(QS) Subject Topics

  • Medicine
  • Pharmacy & Pharmacology

Fingerprint

Dive into the research topics of 'Rhabdomyolysis and neuroleptic malignant syndrome associated with very low-dose antipsychotics in children and adolescent'. Together they form a unique fingerprint.

Cite this